Role of Endoscopic Retrograde Cholangiopancreatography in the Diagnosis and Management of Cholestatic Liver Diseases.
Publication Title
Clinics in liver disease
Document Type
Article
Publication Date
2-1-2022
Keywords
washington; swedish; swedish dhi; Autoimmune cholangiopathy; Cholestatic liver diseases; ERCP; Endoscopic retrograde cholangiopancreatography; Infectious associated cholangiopathy; PSC; Postliver transplant stricture; Primary sclerosing cholangitis
Abstract
Cholestatic liver diseases (CLDs) occur as a result of bile duct injury, emanating into duct obstruction and bile stasis. Advances in radiological imaging in the last decade has replaced endoscopic retrograde cholangiopancreatography (ERCP) as the first diagnostic tool, except in certain groups of patients, such as those with ischemic cholangiopathy (IsC) or early stages of primary sclerosing cholangitis (PSC). ERCP provides an opportunity for targeted tissue acquisition for histopathological evaluation and carries a diverse therapeutic profile to restore bile flow. The aim of this review article is to appraise the diagnostic and therapeutic roles of ERCP in CLDs.
Area of Special Interest
Digestive Health
Specialty/Research Institute
Gastroenterology
Specialty/Research Institute
Swedish Digestive Health Institute